Law Offices of Scott Glovsky

Law Offices of Scott Glovsky The Law Offices of Scott Glovsky was founded in 1999 and specializes in health insurance denials, insurance bad faith, catastrophic injuries, and more.

The HHS announced the cancellation of ACA Marketplace coverage for about 760,000 enrollees, saying the action targets su...
09/23/2026

The HHS announced the cancellation of ACA Marketplace coverage for about 760,000 enrollees, saying the action targets suspected fraudulent or unauthorized enrollments, including cases in which brokers allegedly enrolled people without their knowledge; the administration estimates the move will save more than $2 billion in federal subsidies. However, health-policy experts noted that some legitimate enrollees could potentially be affected if they failed to respond to verification attempts, highlighting the need for greater transparency about how cancellations were identified. The administration is also reviewing roughly 400,000 additional enrollees while continuing broader efforts to strengthen ACA enrollment verification and prevent improper coverage.

The American Medical Association is urging CMS to maintain its January 1, 2027, deadline for implementing electronic pri...
09/22/2026

The American Medical Association is urging CMS to maintain its January 1, 2027, deadline for implementing electronic prior authorization and avoid broad enforcement delays, arguing that continued reliance on faxes, phone calls, and manual payer portals can delay medically necessary care. The AMA cited its 2025 survey showing that 95% of physicians reported prior authorization delays access to necessary care, while physicians and staff spend an average of 13 hours per week handling prior authorizations.

A KFF Health News analysis found that 7% of U.S. healthcare workers were uninsured in 2024, compared with 11% of adults ...
09/21/2026

A KFF Health News analysis found that 7% of U.S. healthcare workers were uninsured in 2024, compared with 11% of adults under 65 overall, as rising premiums and healthcare costs make coverage increasingly unaffordable. Although only 2% of physicians were uninsured, some healthcare professionals are choosing to pay for care out of pocket after marketplace premiums surged, with one Idaho physician couple reporting premiums of nearly $1,600 per month and $9,000 in healthcare expenses in 2026. The expiration of enhanced ACA premium tax credits has further increased costs, raising concerns about healthcare workers foregoing insurance and potentially relying on self-treatment or informal arrangements to manage medical expenses.

The No Surprises Act, enacted in 2020 to protect patients from unexpected out-of-network medical bills, is facing calls ...
09/18/2026

The No Surprises Act, enacted in 2020 to protect patients from unexpected out-of-network medical bills, is facing calls for reform as employers, insurers, and doctors dispute the costs and operation of its arbitration system. Employers argue that a surge in provider disputes and arbitration awards is increasing healthcare spending and could raise employee premiums, while doctors contend that insurers often underpay or delay payments. The dispute system generated 2.6 million cases in 2025, far exceeding Congress’s original expectations, with arbitration costs surpassing $16 billion. Congress is considering changes to address potentially ineligible claims, payment delays, and how reimbursement rates are determined, but stakeholders have not reached consensus.

Nearly one-third of working-age adults with private health insurance are paying medical bills or debt, with the burden p...
09/17/2026

Nearly one-third of working-age adults with private health insurance are paying medical bills or debt, with the burden particularly high among Black adults, Southern residents, and lower-income households. Nearly half of those with medical debt owe at least $2,000, often for hospital care, while many report anxiety, reduced spending on necessities, or delaying needed care because of costs. The findings highlight that having private insurance does not necessarily protect patients from significant medical debt or financial hardship.

A long-running lawsuit involving Data Marketing Partnership and the Department of Labor could affect how certain limited...
09/16/2026

A long-running lawsuit involving Data Marketing Partnership and the Department of Labor could affect how certain limited-partnership health plans are classified and regulated. The company argues that its limited partners should be recognized as employees, allowing them to access self-insured employer health plans that are generally exempt from many state insurance rules and some ACA requirements. Supporters view these plans as a potentially lower-cost alternative, while state regulators and consumer advocates warn that broader availability could reduce consumer protections, expose people to inadequate coverage and large medical bills, and draw healthier people away from ACA marketplaces, potentially increasing premiums for those who remain. The case has already prompted actions and warnings from several states, and court documents indicate a possible settlement, although its terms and the Department of Labor’s current position remain unclear.

Pending California legislation (SB 1094) would allow insurers and pharmacists to swap expensive brand-name biologic drug...
09/15/2026

Pending California legislation (SB 1094) would allow insurers and pharmacists to swap expensive brand-name biologic drugs for cheaper biosimilars, affecting roughly 25,000 residents unless a doctor explicitly objects. Aimed at curbing specialty drug costs to save an estimated $87.7 million annually and slow rising insurance premiums, the bill has drawn criticism from physicians and patient advocates who worry non-medical switches could destabilize effective treatments for complex conditions.

Insurance denials for cancer medications are not always final: a study of nearly 5,000 Medicare Part D appeals found tha...
09/14/2026

Insurance denials for cancer medications are not always final: a study of nearly 5,000 Medicare Part D appeals found that 19.5% of denied anticancer drug claims were overturned on second-level review, with prior-authorization denials succeeding 61% of the time. Insurers may deny newer or off-label cancer treatments as experimental or investigational, even when emerging research and clinical guidelines support their use. A strong appeal typically includes a detailed medical-necessity explanation from the treating physician, supported by relevant guidelines and research, and patients with private insurance may also have the option of an independent external review.

The administration announced that nearly 1 million Affordable Care Act enrollees in 30 states using the federal marketpl...
09/11/2026

The administration announced that nearly 1 million Affordable Care Act enrollees in 30 states using the federal marketplace will receive $500 refunds beginning in October, primarily benefiting middle-income consumers who no longer qualify for premium subsidies. The payments, totaling about $500 million, come after enhanced ACA subsidies expired at the end of 2025, causing premiums to rise and contributing to a decline in marketplace enrollment. Health policy experts note that while the refunds may provide some relief, they are relatively small compared with the thousands of dollars in additional annual premiums many affected consumers now face.

A cancer patient diagnosed at 36 faced repeated health insurance denials after her insurer refused to cover a milder che...
09/10/2026

A cancer patient diagnosed at 36 faced repeated health insurance denials after her insurer refused to cover a milder chemotherapy treatment recommended by her oncologist, insisting instead on a more aggressive standard treatment she had already endured. Her doctor appealed the decision multiple times, warning that delays increased the risk of recurrence, but the insurer continued to deny coverage, leaving the patient facing potentially $324,000 in out-of-pocket costs for the targeted therapy. After she contacted the company’s CEO, executives intervened and approved the treatment, which she completed before going into remission.

Address

299 N. Euclid Avenue, 2nd Floor
Pasadena, CA
91101

Alerts

Be the first to know and let us send you an email when Law Offices of Scott Glovsky posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Business

Send a message to Law Offices of Scott Glovsky:

Share